PreveCeutical Enters Into Loan Agreements

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has entered into a

newsfileJun 17 16:22 ET

Preveceutical Provides Update on Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect

newsfileMay 30 07:00 ET

Preveceutical Announces First Tranche Closing of Private Placement

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that further t

newsfileMay 29 19:11 ET

PreveCeutical Provides Update on Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is providing an update with respect t

newsfileMay 16 20:32 ET

PreveCeutical Announces Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed

newsfileMay 2 18:36 ET

PreveCeutical Medical Prepares For Proof of Concept Preclinical Study For Diabetes, Obesity Dual Gene Therapy Program

PreveCeutical Medical Inc. (PREV.CSE) said Monday that it has started preparations to accelerate completion of its preclinical dual gene therapy program using its in vitro validated Smart-siRNA sequen

MT NewswiresDec 4, 2023 07:57 ET